Association of Polymorphisms in PPARPGC1A, ACE, and DRD2 Genes with Gestational Diabetes Mellitus

Agamurad A. Orazmuradov, Irina V. Bekbaeva, Gayane A. Arakelyan, Marianna Z. Abitova, Khalid Haddad, Alexander M. Lopatin, Sergey I. Kyrtikov, Gulnoza K. Eldashova, Ekaterina V. Mukovnikova, Aleksey A. Lukaev
2021 International Journal of Biomedicine  
The aim of our research was to study the distribution of polymorphic variants of the DRD2/ANKK1 TaqIA (rs1800497 SNP), PPARGC1A rs8192678 SNP, and ACE I/D in gestational diabetes mellitus (GDM). Methods and Results: The study included 383 pregnant women (gestational age of 37.0–41.0 weeks) with GDM and 68 pregnant women without disturbed carbohydrate metabolism. This was a prospective case-control study. All patients were divided into 3 groups. Group 1 included 211 pregnant women with GDM who
more » ... omen with GDM who received diet therapy only; Group 2 included 172 pregnant women with GDM who received insulin therapy; Group 3 included 68 pregnant women without metabolic disorders. For the DRD2/ANKK1 TaqIA (rs1800497 SNP) (A1/A2; T/C), we found that the TT homozygous genotype and T allele prevailed in Groups with GDM compared with Group without metabolic disorders. Conclusion: A study of the DRD2/ANKK1 TaqIA (rs1800497 SNP), PPARGC1A rs8192678 SNP, and ACE I/D revealed statistically significant increased risks for GDM in carriers of the TT genotype and T allele of the DRD2/ANKK1 TaqIA (rs1800497 SNP).
doi:10.21103/Article11(1)_OA8 doaj:fa6473060fa74729be41724583bc17b3 fatcat:h26dsz7s6vhxdfurzrcvdaixqq